SOURCE: Techs Loanstar, Inc

May 31, 2011 08:45 ET

Quture, Inc. Announces Agreement With Keith A. Candiotti, MD, as Associate Medical Director for Launch of Its Revolutionary New Product for Clinical Healthcare Performance Measurement

Company Believes Its Breakthrough "Disruptive" Technology Will Become the International Standard in Healthcare

WEST PALM BEACH, FL--(Marketwire - May 31, 2011) - Techs Loanstar, Inc. (OTCQB: TCLN) (PINKSHEETS: TCLN) today announced additional details regarding its previously announced pending acquisition target, Q'uture, Inc.

Q'uture, Inc. today announced the selection and agreement with Keith A. Candiotti, MD, to lead the launch of its new transformative tool to improve care while significantly and decisively reducing costs in healthcare. Dr. Candiotti is currently Associate Professor of Clinical Anesthesiology and Internal Medicine and Director of Clinical Research; Chief, Division of Perioperative Medicine, University of Miami School of Medicine, Jackson Memorial Medical Center, in Miami, Florida. He received his M.D. degree from the University of Miami School of Medicine in 1989, completed his internship and residency in internal medicine in 1992 and his residency in anesthesiology in 1994.

The existing Q'uture product has recently been significantly enhanced to measure true clinical performance in healthcare. This electronic process does not rely on billing codes as do its competitors, but integrates powerful clinical data from disparate electronic databases in hospitals and physician groups. The initial demonstration project with Dr. Candiotti will prove the technical capabilities of Q'uture's new product and establish its value proposition for all shareholders. As Q'uture strategically positions itself in the marketplace with its "truly disruptive" technology, the company will establish its brand as the only true clinical performance measurement system designed to become the next international standard in the healthcare industry.

Commenting on the agreement with Dr. Candiotti, Landon Feazell, CEO of Q'uture, stated: "We are elated to appoint Dr. Candiotti to lead our clinical and technology teams of experts for product commercialization. Providers, patients, payers, and regulators look to technology companies to provide immediate solutions to improve care, reduce adverse events, and, at the same time, reduce costs. Not only in the United States but internationally, we look to free enterprise solutions to these most demanding challenges and opportunities. Dr. Candiotti embraces our vision for the product and advances its future. He focuses on the needs of physicians and nurses treating patients with optimal medical care. His extensive experience with pharmaceutical companies and personalized medicine research leading to commercialization of products is extraordinary and unique. Dr. Candiotti is motivated to improve clinical processes of care, but also anticipates the financial impact and opportunities from this truly transformative tool. These advances at bedside will translate to powerful and actionable insight for administrators and boards and exceed new and demanding regulations and accreditation standards."

About Q'uture

Q'uture's mission statement is to become the Gold Standard in Healthcare Performance Measurement. Q'uture provides healthcare organizations, insurers, government payers, and other stakeholders in the healthcare community with performance measurement tools and data sets. Industry experts agree that these performance measures are the "transformative tool" that reduce medical cost and improve quality of care. Q'uture's management team has 35 years of experience and a long history of working with many of the nation's leading healthcare institutions as a leader and innovator in measuring clinical performance. Q'uture plans include developing a revolutionary solution to effectively and efficiently measure clinical performance from multiple vendor databases.

About Techs Loanstar, Inc.

Techs Loanstar, Inc., a Nevada company, was initially organized to provide loan management service and software for the equity and payday loan industry. Upon completion of a Share Exchange Agreement in February 2010, Techs ceased all operations relating to its historical business and adopted the business plan of ZenZuu USA, Inc. ("ZZUSA"). ZZUSA was formed to acquire an exclusive license to use and operate in the United States, an online social database and advertising revenue-share model for the purpose of seeking a business opportunity in the online social network industry.

Forward-Looking Statements

This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law. There is no assurance that a definitive agreement will be completed.

Contact Information

  • For Further Information Contact:
    Constellation Asset Advisors, Inc.
    Jens Dalsgaard
    +1 (415) 524-8500